Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pallavi Sachdev

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentPieter Jelle Visser, Pallavi Sachdev, Satya Saxena, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 23, 2026
Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatmentPratik Bhagunde, Natasha Penner, Brian A Willis, et al.
The Journal of Biological Chemistry|January 19, 2002
The role of phosphatidylinositol 3-kinase, rho family GTPases, and STAT3 in Ros-induced cell transformationKevin T Nguyen, Cong S Zong, Shailaja Uttamsingh, et al.
Lung Cancer (Amsterdam, Netherlands)|November 12, 2019
A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinomaToyoaki Hida, Vamsidhar Velcheti, Karen L Reckamp, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 31, 2025
Combining CSF MTBR-tau243 and plasma pTau217 ratio enhances the prediction of continuous regional tau PET burden in early Alzheimer's diseaseViswanath Devanarayan, Kanta Horie, Kristin Wildsmith, et al.
NPJ Systems Biology and Applications|March 6, 2026
Neuro-Dynamic Quantitative Systems Pharmacology (QSP) model describing Alzheimer's disease pathophysiology and treatment effectsYoufang Cao, Brian A Willis, Kanta Horie, et al.
The Journal of Biological Chemistry|November 13, 2007
Site-specific incorporation of keto amino acids into functional G protein-coupled receptors using unnatural amino acid mutagenesisShixin Ye, Caroline Köhrer, Thomas Huber, et al.
The EMBO Journal|May 12, 2007
G protein beta gamma subunit interaction with the dynein light-chain component Tctex-1 regulates neurite outgrowthPallavi Sachdev, Santosh Menon, David B Kastner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2023
Predicting clinical progression trajectories of early Alzheimer's disease patientsViswanath Devanarayan, Yuanqing Ye, Arnaud Charil, et al.
British Journal of Cancer|October 7, 2020
Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinomaChung-Han Lee, Robert J Motzer, Hilary Glen, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentPieter Jelle Visser, Pallavi Sachdev, Satya Saxena, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 23, 2026
Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatmentPratik Bhagunde, Natasha Penner, Brian A Willis, et al.
The Journal of Biological Chemistry|January 19, 2002
The role of phosphatidylinositol 3-kinase, rho family GTPases, and STAT3 in Ros-induced cell transformationKevin T Nguyen, Cong S Zong, Shailaja Uttamsingh, et al.
Lung Cancer (Amsterdam, Netherlands)|November 12, 2019
A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinomaToyoaki Hida, Vamsidhar Velcheti, Karen L Reckamp, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 31, 2025
Combining CSF MTBR-tau243 and plasma pTau217 ratio enhances the prediction of continuous regional tau PET burden in early Alzheimer's diseaseViswanath Devanarayan, Kanta Horie, Kristin Wildsmith, et al.
NPJ Systems Biology and Applications|March 6, 2026
Neuro-Dynamic Quantitative Systems Pharmacology (QSP) model describing Alzheimer's disease pathophysiology and treatment effectsYoufang Cao, Brian A Willis, Kanta Horie, et al.
The Journal of Biological Chemistry|November 13, 2007
Site-specific incorporation of keto amino acids into functional G protein-coupled receptors using unnatural amino acid mutagenesisShixin Ye, Caroline Köhrer, Thomas Huber, et al.
The EMBO Journal|May 12, 2007
G protein beta gamma subunit interaction with the dynein light-chain component Tctex-1 regulates neurite outgrowthPallavi Sachdev, Santosh Menon, David B Kastner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2023
Predicting clinical progression trajectories of early Alzheimer's disease patientsViswanath Devanarayan, Yuanqing Ye, Arnaud Charil, et al.
British Journal of Cancer|October 7, 2020
Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinomaChung-Han Lee, Robert J Motzer, Hilary Glen, et al.
Pageof 4